GeneBio Systems
Anti-PI 3 Kinase catalytic subunit alpha/PIK3CA Antibody Picoband®
Anti-PI 3 Kinase catalytic subunit alpha/PIK3CA Antibody Picoband®
SKU:PB9314
Couldn't load pickup availability
Size: 100 μg
Storage: Store at -20℃ for one year from date of receipt. After reconstitution, at 4℃ for one month. It can also be aliquotted and stored frozen at -20℃ for six months. Avoid repeated freeze-thaw cycles.
Form: Lyophilized
Reactivity: Human
Applications: Flow Cytometry,WB
Application Details: Western blot, 0.1-0.5μg/ml, Human
Flow Cytometry (Fixed), 1-3μg/1x106 cells, Human
Gene Name: PIK3CA
Specificity: No cross reactivity with other proteins.
Background: Phosphatidylinositol-4,5-bisphosphate 3-kinase, also called PIK3CA, is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. PIK3CA gene is mapped to 3q26.32. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate phosphatidylinositols (PtdIns), PtdIns4P andPtdIns(4,5)P2. Recent evidence has shown that the PIK3CA gene is mutated in a range of human cancers. It has been found to be oncogenic and has been implicated in cervical cancers. PIK3CA mutations in breast cancer may be a predictive marker to guide the selection of patients who would benefit from mTOR inhibitor therapy. In addition to that, the presence of PIK3CA mutation may predict response to aspirin therapy for colorectal cancer, indicating power and promise of Molecular Pathological Epidemiology (MPE) approach as well as a complex interaction within the tumor microenvironment in this phenomenon.
Immunogen: E.coli-derived human PIK3CA recombinant protein (Position: H936-N1068). Human PIK3CA shares 98% amino acid (aa) sequence identity with mouse PIK3CA.
Clonality: Polyclonal
Contents: Each vial contains 4mg Trehalose, 0.9mg NaCl and 0.2mg Na2HPO4.
Purification: Immunogen affinity purified.
Reconstitution: Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Reference: 1.Hiles I, Otsu M, Volinia S, Fry M, Gout I, Dhand R et al. (August 1992). Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70 (3): 419–29. 2.Ma Y, Wei S, Lin Y, Lung J, Chang T, Whang-Peng J et al. (May 2000). PIK3CA as an oncogene in cervical cancer. Oncogene 19 (23): 2739–44. 3.Weigelt, B., Warne, P. H., Downward, J. PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. Oncogene 30: 3222-3233, 2011.
Uniprot ID: P42336
Host: Rabbit
Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.
Conjugate: This is the unconjugated antibody. It is also available with 10 conjugation options, including Biotin, Cy3, Fluoro488, Fluoro550, Fluoro594, FITC, HRP, APC, PE, and Fluoro647. A carrier-free (BSA-free) version is also available. Additional charges may apply for some options. Please contact us for a quote
Cross Reactivity: No cross-reactivity with other proteins
Isotype: Rabbit IgG
Phospho_site:
Clone Number:
Observed Molecular Weight: 124 kDa
Calculated Molecular Weight: 124284 MW
Gene ID: 5290
Protein Name: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Gene Full Name: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
Synonyms: p110 alpha; PI3 kinase subunit alpha; PI3K; PI3K alpha; PI3K p110(alpha); PIK3CA; PtdIns 3 kinase subunit alpha
